Citadel Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$376K Buy
9,259
+1,256
+16% +$51K ﹤0.01% 4375
2025
Q1
$389K Buy
8,003
+3,247
+68% +$158K ﹤0.01% 4211
2024
Q4
$209K Sell
4,756
-2,766
-37% -$122K ﹤0.01% 4853
2024
Q3
$421K Buy
+7,522
New +$421K ﹤0.01% 3969
2024
Q2
Sell
-8,210
Closed -$436K 6689
2024
Q1
$436K Buy
+8,210
New +$436K ﹤0.01% 4052
2023
Q4
Sell
-17,020
Closed -$703K 6556
2023
Q3
$703K Buy
17,020
+6,244
+58% +$258K ﹤0.01% 3403
2023
Q2
$480K Sell
10,776
-16,096
-60% -$717K ﹤0.01% 3679
2023
Q1
$1.15M Buy
26,872
+6,356
+31% +$272K ﹤0.01% 3045
2022
Q4
$970K Sell
20,516
-19,014
-48% -$899K ﹤0.01% 3231
2022
Q3
$1.53M Buy
39,530
+17,802
+82% +$687K ﹤0.01% 3010
2022
Q2
$948K Buy
+21,728
New +$948K ﹤0.01% 3464
2021
Q4
Sell
-31,288
Closed -$1.49M 7086
2021
Q3
$1.49M Buy
31,288
+21,064
+206% +$1M ﹤0.01% 3336
2021
Q2
$477K Sell
10,224
-44,712
-81% -$2.09M ﹤0.01% 4759
2021
Q1
$2.19M Buy
54,936
+14,688
+36% +$586K ﹤0.01% 3057
2020
Q4
$1.52M Sell
40,248
-73,820
-65% -$2.79M ﹤0.01% 2856
2020
Q3
$3.73M Buy
114,068
+68,144
+148% +$2.23M ﹤0.01% 1720
2020
Q2
$1.35M Buy
45,924
+1,120
+2% +$32.9K ﹤0.01% 2594
2020
Q1
$1.02M Buy
44,804
+5,352
+14% +$121K ﹤0.01% 2855
2019
Q4
$1.26M Sell
39,452
-6,392
-14% -$203K ﹤0.01% 2790
2019
Q3
$1.13M Buy
45,844
+4,680
+11% +$115K ﹤0.01% 2812
2019
Q2
$1.08M Buy
41,164
+4,528
+12% +$119K ﹤0.01% 2923
2019
Q1
$957K Buy
36,636
+8,876
+32% +$232K ﹤0.01% 2864
2018
Q4
$631K Buy
+27,760
New +$631K ﹤0.01% 3122
2017
Q1
Sell
-17,656
Closed -$265K 4092
2016
Q4
$265K Buy
17,656
+712
+4% +$10.7K ﹤0.01% 2880
2016
Q3
$279K Buy
+16,944
New +$279K ﹤0.01% 2847
2016
Q2
Sell
-14,720
Closed -$211K 3814
2016
Q1
$211K Sell
14,720
-2,640
-15% -$37.8K ﹤0.01% 2688
2015
Q4
$286K Sell
17,360
-22,832
-57% -$376K ﹤0.01% 2746
2015
Q3
$573K Buy
40,192
+29,056
+261% +$414K ﹤0.01% 2519
2015
Q2
$207K Buy
+11,136
New +$207K ﹤0.01% 3027
2014
Q2
Sell
-22,384
Closed -$252K 3689
2014
Q1
$252K Buy
+22,384
New +$252K ﹤0.01% 2719